Raising Awareness of Heavy Menstrual Bleeding
Raising Awareness of Heavy Menstrual Bleeding
Heavy menstrual bleeding is a common sign of a bleeding disorder in women. The suite of resources on bleeding disorders in women and girls includes a short video to raise awareness of heavy menstrual bleeding amongst women and girls.
Heavy menstrual bleeding is a common sign of a bleeding disorder in women. The suite of resources on bleeding disorders in women and girls includes a short video to raise awareness of heavy menstrual bleeding amongst women and girls.
Debra Pollard, Dr Roseline d'Oiron, Prof. Rezan Abdul-Kadir, Dr Sarah O'Brien, Dr Azusa Nagao, Dr Michelle Lavin
A short video to use with patients in your clinical practice
Debra Pollard
Lead Nurse Specialist
Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free ...
United Kingdom (UK)
Dr Roseline d’Oiron
Haematologist
Reference Centre for Haemophilia and Rare Congenital Bleeding Dis...
France
Prof. Rezan Abdul-Kadir
Obstetrician & Gynaecologist
Katharine Dormandy Haemophilia Centre at the Royal Free Hosptial
United Kingdom (UK)
Dr Sarah O’Brien
Paediatric Haematologist
Nationwide Children's Hospital
United States (US)
Dr Azusa Nagao
Haematologist
Ogikubo Hospital
Japan
Dr Michelle Lavin
Haematologist
RCSI and National Coagulation Centre, St. James’ Hospital
Republic of Ireland
Debra Pollard
Lead Nurse Specialist
Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital
United Kingdom (UK)
Debra Pollard is Lead Nurse Specialist, Advanced Nurse Practitioner at Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London, UK. Debra is also Director of Education at Haemnet, a member of the European Haemophilia Consortium’s Medical and Scientific Advisory Group, the UK’s Haemophilia Society as well a member of the Women and Bleeding Disorders Working Group of the EAHAD.
Debra Pollard has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
BioMarin, CSL Behring, Novo Nordisk, Roche-Chugai, Sobi and Takeda.
Dr Roseline d’Oiron
Haematologist
Reference Centre for Haemophilia and Rare Congenital Bleeding Disorders, Bicêtre Hospital AP-HP and University of Paris-Saclay, Le Kremlin–Bicêtre
France
Roseline d’Oiron is a Clinician Investigator and Associate Director at the the Reference Centre for Haemophilia and Rare Congenital Bleeding Disorders at Bicêtre Hospital AP-HP and University of Paris-Saclay, France. She is also responsible for Specialist training for the master’s degree in haematology at University Paris VII. She is the current elected president of the Steering Committee of the FranceCoag Network, a national registry of bleeding disorders, a member of the European Haemophilia Consortium’s Medical and Scientific Advisory Group and a member of the Women and Bleeding Disorders Working Group of the EAHAD.
Dr Roseline d’Oiron has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Biotest, CSL Behring, LFB, Novo Nordisk, Octopharma, Pfizer, Roche, Sobi and Takeda.
Prof. Rezan Abdul-Kadir
Obstetrician & Gynaecologist
Katharine Dormandy Haemophilia Centre at the Royal Free Hosptial
United Kingdom (UK)
Prof. Rezan Abdul-Kadir is a consultant Obstetrician and Gynaecologist, specialised in haemostatic disorders in women. She trained in obstetrics and gynaecology in London and accomplished an MD degree from University of London for her thesis on inherited bleeding disorders in women. She started the first Joint multi-disciplinary clinic for women with bleeding disorders in 2002 and has been leading the service at Katharine Dormandy Haemophilia Centre at the Royal Free hospital. The clinic is internationally renowned for its model of care, its research output in the field and as an international training centre. Her extensive research publications have provided evidence for the prevalence and variety of women’s bleeding disorders and their management, which have established an entire new subspecialty for provision of comprehensive care to this large group of women. She led several national and international guidelines and co-authored a book entitled “Inherited Bleeding Disorders in Women” first edition published in 2009; second edition in 2019. She is currently leading several multi-disciplinary research projects collaborating with international academic teams and scientists in the field of bleeding disorders in women. She has given presentations at numerous international congresses and has authored over 200 peer-reviewed publications. In addition to research and setting the service model, Prof. Rezan Abdul-Kadir has been in the forefront of advocacy for women’s issues in families with bleeding disorders. She led the establishment of “Women Bleed Too project” with the UK Haemophilia society in 2005; and has been chair /member of its medical advisory board since then. This project has become a model for increasing awareness and promoting wellbeing of women and has been replicated in the USA, Canada and in most of Europe. She also plays a leading role in international medical societies, patients’ organisations and NGOs advocating women’s health issues in thrombosis and haemostasis. She is a co-founder and chair/co-chair of committees on women’s health for International Society of Thrombosis and Hemostasis, World Federation of Hemophilia and European Association for Haemophilia and Allied Disorders.
Prof. Rezan Abdul-Kadir has no relevant financial relationships to disclose.
Dr Sarah O’Brien
Paediatric Haematologist
Nationwide Children's Hospital
United States (US)
Dr Sarah O’Brien is Associate Professor of Pediatrics at The Ohio State University College of Medicine. She leads a multi-disciplinary young women’s hematology clinic at Nationwide Children’s Hospital. Her clinical and research interests include the evaluation and diagnosis of mild bleeding disorders and the intersections between hematology and women’s health.
Dr Sarah O’Brien has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Bristol Myers Squibb.
Dr Azusa Nagao
Haematologist
Ogikubo Hospital
Japan
Azusa Nagao, M.D., M.Sc., serves as a hematologist at Ogikubo hospital, Tokyo, Japan that is the biggest hemophilia treatment center. Dr Nagao’s clinical research is focused on problems of women and girls bleeding disorders, ageing problems of hemophilia patients, and musculoskeletal ultrasound systems. Even though Dr Nagao is a young investigator, she has authored and co-authored more than 20 scientific publications, been a speaker at many national and international meetings and congresses.
Dr Azusa Nagao has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Bayer, Chugai, CSL, Fujimoto, JB, KMB, Novo Nordisk, Pfizer, Sanofi and Takeda.
Dr Michelle Lavin
Haematologist
RCSI and National Coagulation Centre, St. James’ Hospital
Republic of Ireland
Dr Michelle Lavin is a Consultant Haematologist in the National Coagulation Centre in St. James’ Hospital, Ireland and a Principal Investigator in the Irish Centre for Vascular Biology in RCSI. She serves as a Co-Chair on the Von Willebrand Factor Scientific Subcommittee of the International Society on Thrombosis and Haemostasis (ISTH) and on the European Association for Haemophilia and Allied Disorders (EAHAD) Women and Bleeding Disorders Committee. Dr Lavin’s research focuses on improving diagnosis and care for women with bleeding disorders and the management of Von Willebrand Disease.
Dr Michelle Lavin has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Tremeau Pharmaceuticals and Sobi.
Video |
1 min
|
Jan 2022
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
Subtitles in English, Spanish, French, German, Swedish and Japanese are available by clicking on ‘CC’ within the video controls
One in five women and girls have heavy periods, often without realising they do.
This short video aims to raise awareness of heavy menstrual bleeding as a possible sign of bleeding disorders amongst women and girls.
Do you see women or girls with heavy menstrual bleeding or any other bleeding symptoms? Refer to our podcast series and micro e-learning programme to learn more.
This video is endorsed by:
HEMOSTASIS CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Takeda, Viatris and Sobi.
Other programmes of interest
Other programmes developed by Debra Pollard
Debra Pollard
Lead Nurse Specialist
Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free ...
United Kingdom (UK)
Other programmes developed by Dr Roseline d'Oiron
Dr Roseline d’Oiron
Haematologist
Reference Centre for Haemophilia and Rare Congenital Bleeding Dis...
France
Other programmes developed by Prof. Rezan Abdul-Kadir
Prof. Rezan Abdul-Kadir
Obstetrician & Gynaecologist
Katharine Dormandy Haemophilia Centre at the Royal Free Hosptial
United Kingdom (UK)